NuVasive Inc. (NSDQ:NUVA) CEO Alex Lukianov is aiming to take the #3 spot in the spinal implant market and has set his sights on the $1 billion sales mark, after NuVasive’s 1st-quarter results showed it taking market share from its larger rivals.
That seems to be music to Wall Street’s ears, as investors bid shares up more than 23% yesterday and analysts issued a slew of upgrades for the San Diego-based company.